亚洲知识产权资讯网为知识产权业界提供一个一站式网上交易平台,协助业界发掘知识产权贸易商机,并与环球知识产权业界建立联系。无论你是知识产权拥有者正在出售您的知识产权,或是制造商需要购买技术以提高操作效能,又或是知识产权配套服务供应商,你将会从本网站发掘到有用的知识产权贸易资讯。

A New Approach for p53 Activation in the Treatment of Cancer (Yissum)

总结
Highlights:
p53, the most important tumour suppressor protein in the cell, is a homotetrameric protein that has a pivotal role in the cellular anti cancer defense mechanism.

p53 is active as a tetramer: the tetramer binds DNA much tighter than the monomer / dimer and is retained in the nucleus while the monomers / dimers are exported and degraded.

Molecules that bind specifically to tetrameric p53 C-terminal domain can potentially activate p53 by stabilizing the active tetramer.

Our Innovation:
We developed peptides that bind preferably to tetrameric p53 through its C-terminal domain and stabilize it.

Key Features:
These peptides may form a basis for developing small anti cancer molecules that activate p53 by shifting its oligomerization equilibrium towards the active tetramer resulting in an increase in the concentration of active p53 and inducing apoptosis of cancer cells.

Development Milestones:
Seeking funding and collaboration with companies working on cancer treatments

The Opportunity:
New approach to cancer treatment
覆盖范围


Cancer therapy
专利信息
Provisional patent application filed
ID号码
7-2010-2561
国家/地区
以色列

欲了解更多信息,请点击 这里
移动设备